Endogenous expression mapping of malignant melanoma by mass spectrometry imaging

BACKGROUND: Currently, only a limited number of molecular biomarkers for malignant melanoma exist. This is the case for both diagnosing the disease, staging, and efficiently measuring the response to therapy by tracing the progression of disease development and drug impact. There is a great need to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Yutaka, Rivas, Daniel, Malm, Johan, Szasz, Marcell, Kwon, HoJeong, Baldetorp, Bo, Olsson, Håkan, Ingvar, Christian, Rezeli, Melinda, Fehniger, Thomas E., Marko-Varga, György
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077138/
https://www.ncbi.nlm.nih.gov/pubmed/30079437
http://dx.doi.org/10.1186/s40169-018-0201-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077138/
https://www.ncbi.nlm.nih.gov/pubmed/30079437
http://dx.doi.org/10.1186/s40169-018-0201-x

Ejemplares similares